Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -3.48 is 60% above its 5-year average of -8.71, near the high end of its 5-year range (-95.14–5.72).
As of the fiscal period ended Tuesday, June 30, 2026. 90.19% above its 12-month average of -35.50.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -3.48.
DEBT TO EQUITY RATIO
-3.48
DEBT TO EQUITY RATIO AVG TTM
-35.50
DEBT TO EQUITY RATIO AVG 3Y
-14.52
DEBT TO EQUITY RATIO AVG 5Y
-8.71
DEBT TO EQUITY RATIO AVG 10Y
0.33
DEBT TO EQUITY RATIO AVG 15Y
0.13
DEBT TO EQUITY RATIO AVG 20Y
0.01
CURRENT VS TTM AVG
+90.19%
CURRENT VS 3Y AVG
+76.02%
CURRENT VS 5Y AVG
+60.04%
CURRENT VS 10Y AVG
-1165.54%
CURRENT VS 15Y AVG
-2777.72%
CURRENT VS 20Y AVG
-36052.28%
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
-3264.83%
vs the sector median at left
MDxHealth S.A.
Market Cap
$30.81M
Debt to Equity Ratio
-3.48
TTM Avg
-35.50
3Y Avg
-14.52
5Y Avg
-8.71
Market Cap
$31.52M
Debt to Equity Ratio
0.50
TTM Avg
0.49
3Y Avg
0.49
5Y Avg
0.65
Market Cap
$30.19M
Debt to Equity Ratio
0.40
TTM Avg
0.38
3Y Avg
0.64
5Y Avg
2.44
Market Cap
$29.74M
Debt to Equity Ratio
0.10
TTM Avg
0.05
3Y Avg
0.16
5Y Avg
0.16
Market Cap
$29.57M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$32.07M
Debt to Equity Ratio
4.41
TTM Avg
3.29
3Y Avg
3.77
5Y Avg
3.62
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.81M | -3.48 | -35.50 | -14.52 | -8.71 |
| CervoMed Inc. (CRVO)vs › | $30.92M | 0.00 | 0.00 | 0.00 | 0.00 |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | 0.03 | 0.17 | 3.90 | 2.92 |
| Nortech Systems Incorporated (NSYS)vs › | $31.52M | 0.50 | 0.49 | 0.49 | 0.65 |
| Rockwell Medical, Inc. (RMTI)vs › | $30.19M | 0.40 | 0.38 | 0.64 | 2.44 |
| HeartBeam, Inc. (BEAT)vs › | $31.79M | 0.00 | 0.00 | 0.00 | 0.00 |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | 0.10 | 0.05 | 0.16 | 0.16 |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | 0.01 | 0.00 | 0.00 | 0.00 |
| Accuray Incorporated (ARAY)vs › | $32.07M | 4.41 | 3.29 | 3.77 | 3.62 |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.42M | 0.00 | 0.00 | 0.00 | 0.03 |
Debt/Equity
-3.48
Current Ratio
1.15
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -3.48 |
| 2025-12-31 | -7.86 |
| 2025-06-30 | -95.14 |
| 2024-12-31 | 4.05 |
| 2024-06-30 | -6.43 |
| 2023-12-31 | 5.72 |
| 2023-06-30 | 1.52 |
| 2022-12-31 | 4.27 |
| 2022-06-30 | 0.48 |
| 2021-12-31 | 0.33 |
| 2021-06-30 | 0.70 |
| 2020-12-31 | 2.71 |
| 2020-06-30 | 0.52 |
| 2019-12-31 | 0.56 |
| 2019-06-30 | 0.05 |
| 2018-12-31 | 0.01 |
| 2018-06-30 | 0.01 |
| 2017-12-31 | 0.02 |
| 2017-06-30 | 0.01 |
| 2016-12-31 | 0.01 |
| 2016-06-30 | 0.02 |
| 2015-12-31 | 0.02 |
| 2015-06-30 | 0.01 |
| 2014-12-31 | 0.00 |
| 2014-06-30 | 0.00 |
| 2013-12-31 | 0.00 |
| 2013-06-30 | 0.00 |
| 2012-12-31 | 0.09 |
| 2012-06-30 | 0.01 |
| 2011-12-31 | 0.01 |
| 2011-06-30 | 0.00 |
| 2010-12-31 | 0.00 |
| 2010-06-30 | 0.00 |
| 2009-12-31 | 0.00 |
| 2009-06-30 | 0.00 |
| 2008-12-31 | 0.00 |
| 2008-06-30 | 0.00 |
| 2007-12-31 | 0.00 |
| 2007-06-30 | 0.00 |
| 2006-12-31 | 0.00 |
| 2006-06-30 | 0.00 |
| 2005-12-31 | 0.00 |
| 2005-06-30 | 0.00 |
| 2004-12-31 | 0.00 |
| 2004-06-30 | 0.00 |
